Tubulin‐binding peptide RR‐171 derived from human umbilical cord serum displays antitumor activity against hepatocellular carcinoma via inducing apoptosis and activating the NF‐kappa B pathway-Reference-Cited by-同舟云学术

Tubulin‐binding peptide RR‐171 derived from human umbilical cord serum displays antitumor activity against hepatocellular carcinoma via inducing apoptosis and activating the NF‐kappa B pathway

Published:2022-05 Issue:5 Volume:55 Page:
ISSN:0960-7722
Container-title:Cell Proliferation
language:en
Short-container-title:Cell Proliferation

Author:

Zhu Donglie¹²^ORCID,Fang Cheng³,Yang Zelong¹,Ren Yanjie⁴,Yang Fengrui⁵,Zheng Shi¹,Jiang Mingzuo⁶,Miao Xiangxia⁷,Liu Duoduo⁴,Chen Biliang⁴,Yao Xuebiao⁵,Chen Yong¹^ORCID

Affiliation:

1. Department of Hepatobiliary Surgery, Xijing Hospital Fourth Military Medical University Xi'an China

2. Department of Hand and Foot Surgery The Air Force Hospital of Northern Theater of People's Liberation Army of China Shenyang China

3. Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital Second Military Medical University Shanghai China

4. Department of Gynecology and Obstetrics, Xijing Hospital Fourth Military Medical University China

5. MOE Key Laboratory for Membraneless Organelles & Cellular Dynamics and Hefei National Laboratory for Physical Sciences at the Microscale University of Science and Technology of China Hefei China

6. Department of Gastroenterology and Hepatology, Jinling Hospital Medical School of Nanjing University Nanjing China

7. Department of General Practice Xianyang Central Hospital Xianyang China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cpr.13241

Reference39 articles.

1. Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities

2. Epidemiology of Hepatocellular Carcinoma

3. Management of hepatocellular carcinoma

4. Rising Incidence of Hepatocellular Carcinoma in the United States

5. Hepatocellular carcinoma (HCC): beyond sorafenib—chemotherapy

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of CAF-related genes in immunotherapy and drug sensitivity in hepatocellular carcinoma: a multi-database analysis;Genes & Immunity;2024-01-17

2. Peroxiredoxin 1 alleviates oxygen-glucose deprivation/ reoxygenation injury in N2a cells via suppressing the JNK/ caspase-3 pathway;IRAN J BASIC MED SCI;2023